System and method for correcting patient index
A system and/or method for determining an immune activation state of a subject can include: deforming leukocytes within a microfluidic channel, acquiring a plurality of images of the leukocytes, determining biophysical parameters of the leukocyte, adjusting the biophysical parameters, and determining the immune activation state of the subject based on the biophysical parameters.
1. A system for determining an immune activation state of a subject comprising:
a microfluidic device comprising an inlet, an outlet, an alignment region configured to align particles within the microfluidic device, and a deformation region configured to deform particles, wherein the microfluidic device is configured to receive a plurality of leukocytes from a subject blood sample;
an image acquisition system, wherein a field-of-view of the image acquisition system captures the deformation region of the microfluidic device;
a processor; and
a non-transitory computer-readable medium programmed with instructions that causes the processor to:
control the image acquisition system to capture a plurality of images of each leukocyte in the plurality of leukocytes;
for each leukocyte of interest in a set of leukocytes in the plurality of leukocytes:
determine one or more biophysical parameters of the leukocyte of interest based on the plurality of images;
determine a type of the leukocyte of interest; and
adjust the one or more biophysical parameters based on the type and at least one of a flow rate or a path traversed by the leukocyte of interest;
determine an index based on the adjusted one or more biophysical parameters for the set of leukocytes in the plurality of leukocytes; and
based on the index, determining the immune activation state of the subject.
2. The system of claim 1 , wherein the non-transitory computer-readable medium is further programmed with instructions that causes the processor to: detect overlapping leukocytes in an image of a first leukocyte in the plurality of leukocytes; and exclude the first leukocyte from the set of leukocytes.
3. The system of claim 2 , wherein the overlapping leukocytes are detected based on a monotonicity in feature motion between images of the first leukocyte.
4. The system of claim 1 , wherein the non-transitory computer-readable medium is further programmed with instructions that causes the processor to determine an entrance position of a first leukocyte in the plurality of leukocytes into the deformation region and an exit position of the first leukocyte from the deformation region; and exclude the first leukocyte from the set of leukocytes when the entrance position or the exit position differ from an expected entrance or expected exit position.
5. The system of claim 1 , wherein the type of the leukocyte of interest is determined based on a cell size and an optical intensity.
6. The system of claim 1 , wherein when the processor determines that the type of the leukocyte of interest is a neutrophil, the adjusting the one or more biophysical parameters comprises adjusting the one or more biophysical parameters based on a z-plane of the leukocyte of interest.
7. The system of claim 1 , wherein the non-transitory computer-readable medium is further programmed with instructions that causes the processor to: determine a handedness of the path traversed by the leukocyte of interest, wherein adjusting the one or more biophysical parameters based on the path comprises linearly adjusting the one or more biophysical parameters when the path of the leukocyte of interest comprises a first handedness and not linearly adjusting the one or more biophysical parameters when the path of the leukocyte of interest comprises a second handedness.
8. The system of claim 1 , wherein the non-transitory computer-readable medium is further programmed with instructions that causes the processor to determine the index based on an average size of neutrophils and a 75 th percentile of a trajectory of leukocytes in the deformation region.
9. The system of claim 1 , wherein the non-transitory computer-readable medium is further programmed with instructions that causes the processor to: determine an average velocity of the plurality of leukocytes through the microfluidic device, wherein the immune activation state of the subject is not determined when an average velocity of the plurality of leukocytes through the microfluidic device is less than 1 m/s or greater than 5 m/s.